Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App





New Patented Technology Determines Who Should Receive COVID-19 Vaccine First by Tracing Coronavirus “Super Distributors”

By HospiMedica International staff writers
Posted on 23 Sep 2020
A new technology aims to determine which people should be first given the COVID-19 vaccine before the rest of the population to effectively stop the spread of the SARS-CoV-2 virus.

The technology developed by the Ehrlich Group (Ramat-Gan, Israel) was recently filed for a patent in the United Arab Emirates’ patent office, according to a report by the Jerusalem Post. More...
The long-awaited COVID-19 vaccine is just months away from potentially curing the world from the SARS-CoV-2 virus, although it would take years to manufacture, distribute and vaccinate the entire world population.

Using data about the number of contacts and interactions by each individual, the new patented technology will establish priority guidelines for the vaccination of the population against COVID-19. The technology will trace "super-distributors” of the SARS-CoV-2 virus who will be given priority for administering the COVID-19 vaccine. The technology is based on the analysis of data collected from Israeli intelligence agencies or from various apps where users approve the use of their location data. By tracing and vaccinating super distributors of the SARS-CoV-2 virus, the chains of transmissions and infections within the community can be broken, making it possible to stop the spread of the SARS-CoV-2 virus even before the entire population is vaccinated, thus saving time and money, according to the Jerusalem Post report.

Related Links:
Ehrlich Group


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Gynecological Examination Chair
arco-matic
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.